Published in Hum Antibodies Hybridomas on January 01, 1994
Agalactosylated IgG antibodies depend on cellular Fc receptors for in vivo activity. Proc Natl Acad Sci U S A (2007) 1.66
The role of sialic acid as a modulator of the anti-inflammatory activity of IgG. Semin Immunopathol (2012) 1.11
Identification of antibody glycosylation structures that predict monoclonal antibody Fc-effector function. AIDS (2014) 0.88
The p68 autoantigen characteristic of rheumatoid arthritis is reactive with carbohydrate epitope specific autoantibodies. Ann Rheum Dis (1998) 0.88
The Serum Immunoglobulin G Glycosylation Signature of Gastric Cancer. EuPA Open Proteom (2015) 0.83
Enrichment strategies in glycomics-based lung cancer biomarker development. Proteomics Clin Appl (2013) 0.82
Impact of Glycosylation on Effector Functions of Therapeutic IgG. Pharmaceuticals (Basel) (2010) 0.81
Anti-rhesus D prophylaxis in pregnant women is based on sialylated IgG antibodies. F1000Res (2013) 0.78
Agalactosyl IgG and beta-1,4-galactosyltransferase gene expression in rheumatoid arthritis patients and in the arthritis-prone MRL lpr/lpr mouse. Immunology (1996) 0.78
Surrogate target cells expressing surface anti-idiotype antibody for the clinical evaluation of an internalizing CD22-specific antibody. MAbs (2015) 0.76
The impact of microcarrier culture optimization on the glycosylation profile of a monoclonal antibody. Springerplus (2013) 0.75
Human Cell Line-Derived Monoclonal IgA Antibodies for Cancer Immunotherapy. Bioengineering (Basel) (2017) 0.75
Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature (1985) 5.32
Physician manipulation of reimbursement rules for patients: between a rock and a hard place. JAMA (2000) 4.31
Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. Immunology (1986) 3.98
Persistence of DNA from Mycobacterium tuberculosis in superficially normal lung tissue during latent infection. Lancet (2001) 3.71
A simple new method for using antigens separated by polyacrylamide gel electrophoresis to stimulate lymphocytes in vitro after converting bands cut from Western blots into antigen-bearing particles. J Immunol Methods (1987) 3.56
A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro. J Bone Miner Res (2001) 3.43
Glycosyl-phosphatidylinositol moiety that anchors Trypanosoma brucei variant surface glycoprotein to the membrane. Science (1988) 3.41
Characterization of fibronectin-binding antigens released by Mycobacterium tuberculosis and Mycobacterium bovis BCG. Infect Immun (1988) 3.35
Activation of macrophages to inhibit proliferation of Mycobacterium tuberculosis: comparison of the effects of recombinant gamma-interferon on human monocytes and murine peritoneal macrophages. Immunology (1986) 3.33
Lipoarabinomannan from Mycobacterium tuberculosis induces the production of tumour necrosis factor from human and murine macrophages. Clin Exp Immunol (1989) 3.09
Bacterioplankton: a sink for carbon in a coastal marine plankton community. Science (1986) 2.76
I-A restricted activation by T cell lines of anti-tuberculosis activity in murine macrophages. Clin Exp Immunol (1985) 2.73
Germ-line transmission of a planned alteration made in a hypoxanthine phosphoribosyltransferase gene by homologous recombination in embryonic stem cells. Proc Natl Acad Sci U S A (1989) 2.59
Mycobacterium tuberculosis DNA in tissue affected by sarcoidosis. BMJ (1993) 2.58
Adjusting for patient characteristics when analyzing reports from patients about hospital care. Med Care (2001) 2.46
Tumour necrosis factor in bronchopulmonary secretions of patients with adult respiratory distress syndrome. Lancet (1989) 2.43
Enzymic parameters: measurement of V and Km. Biochim Biophys Acta (1971) 2.42
Insect cells as hosts for the expression of recombinant glycoproteins. Glycoconj J (1999) 2.40
A simple method for the solubilisation of reduced NBT, and its use as a colorimetric assay for activation of human macrophages by gamma-interferon. J Immunol Methods (1985) 2.38
The secreted antigens of Mycobacterium tuberculosis and their relationship to those recognized by the available antibodies. J Gen Microbiol (1988) 2.38
How environmental mycobacteria may predetermine the protective efficacy of BCG. Tubercle (1981) 2.34
Health-related quality of life in patients with human immunodeficiency virus infection in the United States: results from the HIV Cost and Services Utilization Study. Am J Med (2000) 2.31
Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing. J Biol Chem (1986) 2.22
Complete structure of the glycosyl phosphatidylinositol membrane anchor of rat brain Thy-1 glycoprotein. Nature (1988) 2.17
The role of TNF-alpha in T-cell-mediated inflammation depends on the Th1/Th2 cytokine balance. Immunology (1994) 2.08
Type 2 cytokine gene activation and its relationship to extent of disease in patients with tuberculosis. J Infect Dis (2000) 2.08
Cellular immune response to common mycobacterial antigens in subjects seropositive for Trypanosoma cruzi. Lancet (1994) 2.06
Management of failed oral fibreoptic intubation with laryngeal mask airway insertion under topical anaesthesia. Can J Anaesth (1993) 2.05
Characterization of T cell antigens associated with the cell wall protein-peptidoglycan complex of Mycobacterium tuberculosis. J Immunol (1989) 2.01
Measles mortality and vaccine efficacy in rural West Africa. Lancet (1983) 1.97
A conceptual model of the effects of health care organizations on the quality of medical care. JAMA (1998) 1.96
Smoking and tuberculosis: the epidemiological association and immunopathogenesis. Trans R Soc Trop Med Hyg (2005) 1.88
Phospholipids of bacteria with extensive intracytoplasmic membranes. Science (1966) 1.85
Raised serum IgG and IgA antibodies to mycobacterial antigens in rheumatoid arthritis. Ann Rheum Dis (1989) 1.85
Preliminary taxonomic studies on the leprosy bacillus. Br J Exp Pathol (1975) 1.83
Actions of bisphosphonate on bone metastasis in animal models of breast carcinoma. Cancer (2000) 1.78
Role of activated macrophages in the immunopathology of tuberculosis. Br Med Bull (1988) 1.75
Aminosugar derivatives as potential anti-human immunodeficiency virus agents. Proc Natl Acad Sci U S A (1988) 1.75
Genetic and immunological analysis of Mycobacterium tuberculosis fibronectin-binding proteins. Infect Immun (1991) 1.69
Effector functions of a monoclonal aglycosylated mouse IgG2a: binding and activation of complement component C1 and interaction with human monocyte Fc receptor. Mol Immunol (1985) 1.68
Tissue-specific N-glycosylation, site-specific oligosaccharide patterns and lentil lectin recognition of rat Thy-1. EMBO J (1987) 1.66
Structure, biosynthesis, and function of glycosylphosphatidylinositols. Biochemistry (1990) 1.63
Cell-cell contact between marrow stromal cells and myeloma cells via VCAM-1 and alpha(4)beta(1)-integrin enhances production of osteoclast-stimulating activity. Blood (2000) 1.59
The bisphosphonate ibandronate promotes apoptosis in MDA-MB-231 human breast cancer cells in bone metastases. Cancer Res (2001) 1.57
Specific detection of Mycobacterium paratuberculosis DNA associated with granulomatous tissue in Crohn's disease. Gut (1994) 1.57
Attachment of mycobacteria to fibronectin-coated surfaces. J Gen Microbiol (1988) 1.56
Use of bisphosphonates for the treatment of bone metastasis in experimental animal models. Cancer Treat Rev (1999) 1.55
An inhibitor of the toxicity of tumour necrosis factor in the serum of patients with sarcoidosis, tuberculosis and Crohn's disease. Clin Exp Immunol (1990) 1.53
Antibody levels to mycobacteria in relation to HLA type: evidence for non-HLA-linked high levels of antibody to the 65 kD heat shock protein of M. bovis in rheumatoid arthritis. Clin Exp Immunol (1988) 1.53
Elevated IgG antibody levels to the mycobacterial 65-kDa heat shock protein are characteristic of patients with rheumatoid arthritis. Scand J Immunol (1989) 1.49
Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2. J Clin Invest (1997) 1.49
Autoimmune reactions to heat-shock proteins in pristane-induced arthritis. Eur J Immunol (1990) 1.48
Galactosylation of IgG associated oligosaccharides: reduction in patients with adult and juvenile onset rheumatoid arthritis and relation to disease activity. Lancet (1988) 1.46
The beta 1----2-D-xylose and alpha 1----3-L-fucose substituted N-linked oligosaccharides from Erythrina cristagalli lectin. Isolation, characterisation and comparison with other legume lectins. Eur J Biochem (1987) 1.45
Inhibition of an established allergic response to ovalbumin in BALB/c mice by killed Mycobacterium vaccae. Immunology (1998) 1.44
Characterization of the cross-reacting determinant (CRD) of the glycosyl-phosphatidylinositol membrane anchor of Trypanosoma brucei variant surface glycoprotein. Eur J Biochem (1988) 1.43
Aberrant control of galactosyltransferase in peripheral B lymphocytes and Epstein-Barr virus transformed B lymphoblasts from patients with rheumatoid arthritis. J Rheumatol (1993) 1.43
Evaluation of the single-item self-rating adherence scale for use in routine clinical care of people living with HIV. AIDS Behav (2013) 1.41
Human and murine macrophages produce TNF in response to soluble antigens of Plasmodium falciparum. Parasite Immunol (1990) 1.40
The Clq receptor site on immunoglobulin G. Nature (1980) 1.40
The immunological consequences of antigen overload in experimental mycobacterial infections of mice. Clin Exp Immunol (1975) 1.35
Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure. Proc Natl Acad Sci U S A (1994) 1.35
Optimizing care for persons with HIV infection. Society of General Internal Medicine AIDS Task Force. Ann Intern Med (1999) 1.34
Genome-wide association studies of female reproduction in tropically adapted beef cattle. J Anim Sci (2011) 1.33
Fucose in N-glycans: from plant to man. Biochim Biophys Acta (1999) 1.32
Three forms of delayed skin-test response evoked by mycobacteria. Nature (1978) 1.32
Structure of the major carbohydrate fragment of the Leishmania donovani lipophosphoglycan. Biochemistry (1987) 1.31
Effect of mycobacteria on sensitivity to the cytotoxic effects of tumor necrosis factor. Infect Immun (1991) 1.31
Preliminary evidence for the trapping of antigen-specific lymphocytes in the lymphoid tissue of 'anergic' tuberculosis patients. Clin Exp Immunol (1976) 1.30
E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model. Cancer Res (1996) 1.30
Taking antiretroviral therapy for HIV infection: learning from patients' stories. J Gen Intern Med (2000) 1.29
The conformational effects of N-glycosylation on the tailpiece from serum IgM. Eur J Biochem (1991) 1.28
Identification of core alpha 1,3-fucosylated glycans and cloning of the requisite fucosyltransferase cDNA from Drosophila melanogaster. Potential basis of the neural anti-horseadish peroxidase epitope. J Biol Chem (2001) 1.28
Responsiveness to live M. tuberculosis, and common antigens, of sonicate-stimulated T cell lines from normal donors. Clin Exp Immunol (1986) 1.28
The effect of lymph-node cells from specifically sensitised mice, on the growth of the BP8 ascites tumor "in vivo" and "in vitro". Br J Exp Pathol (1968) 1.28
Immunoglobulin G as a glycoprotein. Biochem Soc Symp (1986) 1.27
Cantilever-based sensing: the origin of surface stress and optimization strategies. Nanotechnology (2010) 1.26
Structural characterization of the asparagine-linked oligosaccharides from Trypanosoma brucei type II and type III variant surface glycoproteins. J Biol Chem (1991) 1.24
Glycolipid precursors for the membrane anchor of Trypanosoma brucei variant surface glycoproteins. I. Can structure of the phosphatidylinositol-specific phospholipase C sensitive and resistant glycolipids. J Biol Chem (1990) 1.23
Use of the ELISA to screen for anti-thymocyte and anti-beta 2-microglobulin antibodies in leprosy and SLE. Immunology (1980) 1.22
The effect of two distinct forms of cell-mediated response to mycobacteria on the protective efficacy of BCG. Tubercle (1981) 1.22
Solution structure of the glycosylphosphatidylinositol membrane anchor glycan of Trypanosoma brucei variant surface glycoprotein. Biochemistry (1989) 1.21
The potentiating, mitogenic and inhibitory effects on lymphocytes in vitro, of macrophages in the lymph nodes of mice 'overloaded' with mycobacterial products. Clin Exp Immunol (1975) 1.21
Molecular cloning and functional expression of beta1, 2-xylosyltransferase cDNA from Arabidopsis thaliana. FEBS Lett (2000) 1.21
Effects of different monetary incentives on the return rate of a national mail survey of physicians. Med Care (2001) 1.20
Taxonomic studies on the leprosy bacillus. Int J Lepr Other Mycobact Dis (1976) 1.19
HLA-DR3 associated genetic control of response to multiple skin tests with new tuberculins. Clin Exp Immunol (1983) 1.19
An inexpensive, portable, battery-operated photometer for the reading of ELISA tests in microtitration plates. J Immunol Methods (1981) 1.19
The inhibition of cholinesterase by diethyl phosphorochloridate. Biochim Biophys Acta (1972) 1.18
Analysis of glycosylation changes in IgG using lectins. J Immunol Methods (1990) 1.17
O-linked oligosaccharides from human serum immunoglobulin A1. Biochem Soc Trans (1989) 1.17
Does antibody to mycobacterial antigens, including lipoarabinomannan, limit dissemination in childhood tuberculosis? Trans R Soc Trop Med Hyg (1993) 1.17
Interpretation of Mycobacterium tuberculosis antigen-specific IFN-gamma release assays (T-SPOT.TB) and factors that may modulate test results. J Infect (2007) 1.17
Bacterial delivery of a novel cytolysin to hypoxic areas of solid tumors. Gene Ther (2009) 1.17
The effect of protease inhibitors on weight and body composition in HIV-infected patients. AIDS (1998) 1.17
The effect of Mycobacterium tuberculosis on the susceptibility of human cells to the stimulatory and toxic effects of tumour necrosis factor. Immunology (1992) 1.16
Composition of N-linked carbohydrates from ovalbumin and co-purified glycoproteins. J Am Soc Mass Spectrom (2000) 1.16
Maintained pregnancy levels of oestrogen afford complete protection from post-partum exacerbation of collagen-induced arthritis. Clin Exp Immunol (1991) 1.15
A simple spectrophotometric assay for amino acyl arylamidases (naphthylamidases, aminopeptidases). Anal Biochem (1971) 1.15